4//SEC Filing
PALLARES EBETUEL 4
Accession 0001209191-20-021486
CIK 0001274737other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 6:07 PM ET
Size
15.3 KB
Accession
0001209191-20-021486
Insider Transaction Report
Form 4
EXAGEN INC.XGN
PALLARES EBETUEL
Director
Transactions
- Exercise/Conversion
Warrants
2020-03-11−2,265→ 0 total(indirect: See footnote)Exercise: $1.84→ Common Stock (2,265 underlying) - Tax Payment
Common Stock
2020-03-11$19.51/sh−214$4,174→ 144,033 total(indirect: See footnote) - Exercise/Conversion
Common Stock
2020-03-11$1.84/sh+22,427$41,266→ 144,094 total(indirect: See footnote) - Tax Payment
Common Stock
2020-03-11$19.51/sh−2,112$41,199→ 141,982 total(indirect: See footnote) - Exercise/Conversion
Common Stock
2020-03-11$1.84/sh+2,265$4,168→ 144,247 total(indirect: See footnote) - Exercise/Conversion
Warrants
2020-03-11−22,427→ 0 total(indirect: See footnote)Exercise: $1.84→ Common Stock (22,427 underlying)
Footnotes (4)
- [F1]The shares reported on this form are held of record by PCM/Exagen, L.P. ("PCM"). Ebetuel Pallares is a co-manager of PCM. As a result, each of PCM and Dr. Pallares may be deemed to share beneficial ownership of the shares held of record by PCM.
- [F2]Represents the cashless net exercise of a warrant through the surrender of shares to the Issuer based on a fair market value of $19.507 per share, as determined by the average closing price of the Issuer's common stock for the ten trading days immediately preceding the date of exercise.
- [F3]The warrants are currently exercisable and will expire on January 19, 2026.
- [F4]The warrants are currently exercisable and will expire on March 31, 2026.
Documents
Issuer
EXAGEN INC.
CIK 0001274737
Entity typeother
Related Parties
1- filerCIK 0001614597
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 6:07 PM ET
- Size
- 15.3 KB